This federal contract award, valued at $8,219.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,739,444 units of 10 mg Methylphenidate chewable tablets. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price delivery order.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, AmerisourceBergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
This contract award was not designated with any set-aside requirements, indicating open competition. The primary contracting agency is the DLA, with the contract supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions.